|Mr. Steven A. Sherman||Exec. Chairman||93.7k||N/A||1946|
|Mr. Jack Peurach||Pres, CEO & Director||334.63k||N/A||1966|
|Mr. John F. Glenn||CFO & Sec.||155.24k||N/A||1962|
|Mr. William R. Shaw||Chief Commercial Officer||N/A||N/A||1974|
|Ms. Foon Lim Chwee||Pres of APAC||N/A||N/A||N/A|
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Ekso Bionics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.